Literature DB >> 9973530

The CD8beta ectodomain contributes to the augmented coreceptor function of CD8alphabeta heterodimers relative to CD8alphaalpha homodimers.

T Witte1, R Spoerl, H C Chang.   

Abstract

Within the lymphoid compartment, CD8 is expressed either as an alphaalpha homodimer or as an alphabeta heterodimer. Prior functional characterization of CD8alpha transfectants has demonstrated that CD8alphaalpha homodimers can reconstitute T cell responses in the absence of the CD8beta subunit. In order to now examine the role of CD8beta in TCR recognition, the CD8alpha cDNA alone or in combination with CD8beta cDNA was transfected into the mouse T cell hybridoma, N15wt, specific for VSV8/Kb. Comparison of antigen-induced IL-2 production reveals that CD8alphabeta+ transfectants are 100-fold more sensitive in molar terms of peptide than CD8alphaalpha+ transfectants. This enhancement of IL-2 production is independent of CD8alpha or CD8beta cytoplasmic tails as demonstrated by analysis of cytoplasmic deletion mutants CD8alpha'beta, CD8alphabeta', and CD8alpha'beta'. These results indicate that the ectodomain of the CD8beta chain greatly enhances the coreceptor function of the CD8alphabeta molecule, at least for certain class I MHC restricted alphabeta TCRs. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973530     DOI: 10.1006/cimm.1998.1412

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Characterization of avian γδ T-cell subsets after Salmonella enterica serovar Typhimurium infection of chicks.

Authors:  Jana Pieper; Ulrich Methner; Angela Berndt
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.

Authors:  Ralf-Holger Voss; Jürgen Kuball; Renate Engel; Philippe Guillaume; Pedro Romero; Christoph Huber; Matthias Theobald
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Antigen-specific proliferation of porcine CD8alphaalpha cells to an extracellular bacterial pathogen.

Authors:  W R Waters; R Hontecillas; R E Sacco; F A Zuckermann; K R Harkins; J Bassaganya-Riera; M J Wannemuehler
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

Review 4.  Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy.

Authors:  Sunny J Patel; Takayoshi Yamauchi; Fumito Ito
Journal:  Surg Oncol Clin N Am       Date:  2019-04-10       Impact factor: 3.495

5.  Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Authors:  Rui Wang; Kannan Natarajan; David H Margulies
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

6.  CD8beta/CD28 expression defines functionally distinct populations of peripheral blood T lymphocytes.

Authors:  S Werwitzke; A Tiede; B E Drescher; R E Schmidt; T Witte
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

7.  The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I.

Authors:  D A Shore; H Issafras; E Landais; L Teyton; I A Wilson
Journal:  J Mol Biol       Date:  2008-10-07       Impact factor: 5.469

8.  Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.

Authors:  Inez Johanna; Patricia Hernández-López; Sabine Heijhuurs; Wouter Scheper; Laura Bongiovanni; Alain de Bruin; Dennis X Beringer; Rimke Oostvogels; Trudy Straetemans; Zsolt Sebestyen; Jürgen Kuball
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

9.  Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells.

Authors:  Marleen M van Loenen; Renate S Hagedoorn; Renate de Boer; J H Frederik Falkenburg; Mirjam H M Heemskerk
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.